Sarolaner, Moxidectin, Pyrantel
42 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
42
Total Reports
6
Deaths Reported
1430.0%
Death Rate
Active Ingredients
Sarolaner, Moxidectin, Pyrantel
Administration Routes
UnknownOral
Species Affected
Dog 41
Unknown 1
Most Affected Breeds
Retriever - Labrador 4
Retriever - Golden 3
Beagle 3
Chihuahua 2
Crossbred Canine/dog 2
Pit Bull 2
Terrier - Yorkshire 2
Shepherd Dog - German 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Unknown 1
Most Reported Reactions
Vomiting 11
Lethargy (see also Central nervous system depression in Neurological) 8
Diarrhoea 7
Death 4
Abnormal cytology 4
Lack of efficacy (endoparasite) - heartworm 3
Seizure NOS 3
Necropsy performed 3
Pancreas disorder 3
Anorexia 3
Not eating 3
Incorrect route of drug administration 3
Outcome Breakdown
Outcome Unknown
17 (41.5%)
Recovered/Normal
11 (26.8%)
Ongoing
7 (17.1%)
Euthanized
3 (7.3%)
Died
3 (7.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.